Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant chemotherapy with early intravesical instillation of adriamycin and long-term oral administration of 5-fluorouracil in superficial bladder cancer. The Kyushu University Urological Oncology Group.
Ueda T, Naito S, Iguchi A, Sagiyama K, Osada Y, Ariyoshi A, Omoto T, Kumazawa J. Ueda T, et al. Among authors: sagiyama k. Cancer Chemother Pharmacol. 1992;30 Suppl:S31-6. doi: 10.1007/BF00686938. Cancer Chemother Pharmacol. 1992. PMID: 1394813 Clinical Trial.
Prophylactic intravesical instillation chemotherapy against recurrence after a transurethral resection of superficial bladder cancer: a randomized controlled trial of doxorubicin plus verapamil versus doxorubicin alone. The Kyushu University Urological Oncology Group.
Naito S, Kotoh S, Omoto T, Osada Y, Sagiyama K, Iguchi A, Ariyoshi A, Hiratsuka Y, Kumazawa J. Naito S, et al. Among authors: sagiyama k. Cancer Chemother Pharmacol. 1998;42(5):367-72. doi: 10.1007/s002800050831. Cancer Chemother Pharmacol. 1998. PMID: 9771950 Clinical Trial.
Significance of the preoperative intravesical instillation of doxorubicin and the oral administration of 5-fluorouracil in preventing recurrence after a transurethral resection of superficial bladder cancer. Kyushu University Urological Oncology Group.
Naito S, Iguchi A, Sagiyama K, Ariyoshi A, Osada Y, Omoto T, Kuriya N, Kumazawa J. Naito S, et al. Among authors: sagiyama k. Int J Urol. 1997 Jul;4(4):352-7. doi: 10.1111/j.1442-2042.1997.tb00207.x. Int J Urol. 1997. PMID: 9256323 Free article. Clinical Trial.
99 results